TB500 10mg

Quickstart Highlights

TB‑500 is a synthetic peptide fragment corresponding to the active region of thymosin beta‑4 (Tβ4), a naturally occurring 43‑amino‑acid protein involved in tissue repair and regeneration[1][2]. This educational protocol presents a once‑daily subcutaneous approach using a practical dilution for accurate insulin‑syringe measurements in research settings.

Reconstitute: Add 3.0 mL bacteriostatic water → ~3.33 mg/mL concentration.
Typical daily range: 500–1000 mcg once daily (gradual titration recommended).
Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U‑100 insulin syringe.
Storage: Lyophilized: store at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); do not freeze reconstituted solution.

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

Standard / Gradual Approach (3 mL = ~3.33 mg/mL)

Phase	Daily Dose (mcg)	Units (per injection) (mL)
Weeks 1–2	500 mcg	15 units (0.15 mL)
Weeks 3–4	600 mcg	18 units (0.18 mL)
Weeks 5–8	750 mcg	23 units (0.23 mL)
Weeks 9–12	1000 mcg	30 units (0.30 mL)

Frequency: Inject once daily subcutaneously. This schedule uses the largest practical dilution (3.0 mL) to keep per‑injection units in a comfortable range for accurate measurement. Total weekly dose averages ~5 mg, consistent with research protocols[3][4].

Reconstitution Steps

Reference-derived details for TB500 10mg.

Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label with date and concentration; refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Supplies Needed

Plan based on an 8–16 week daily protocol with gradual titration.

Peptide Vials (TB‑500, 10 mg each):
Peptide Vials (TB‑500, 10 mg each):: 8 weeks ≈ 4 vials
Peptide Vials (TB‑500, 10 mg each):: 12 weeks ≈ 7 vials
Peptide Vials (TB‑500, 10 mg each):: 16 weeks ≈ 10 vials
Insulin Syringes (U‑100):
Insulin Syringes (U‑100):: Per week: 7 syringes (1/day)
Insulin Syringes (U‑100):: 8 weeks: 56 syringes
Insulin Syringes (U‑100):: 12 weeks: 84 syringes
Insulin Syringes (U‑100):: 16 weeks: 112 syringes
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.: 8 weeks (4 vials): 12 mL → 2 × 10 mL bottles
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.: 12 weeks (7 vials): 21 mL → 3 × 10 mL bottles
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.: 16 weeks (10 vials): 30 mL → 3 × 10 mL bottles
Alcohol Swabs: One for the vial stopper + one for the injection site each day.
Alcohol Swabs: One for the vial stopper + one for the injection site each day.: Per week: 14 swabs (2/day)
Alcohol Swabs: One for the vial stopper + one for the injection site each day.: 8 weeks: 112 swabs → recommend 2 × 100‑count boxes
Alcohol Swabs: One for the vial stopper + one for the injection site each day.: 12 weeks: 168 swabs → recommend 2 × 100‑count boxes
Alcohol Swabs: One for the vial stopper + one for the injection site each day.: 16 weeks: 224 swabs → recommend 3 × 100‑count boxes

Protocol Overview

Concise summary of the once‑daily regimen.

Goal: Support tissue repair, wound healing, and angiogenesis through the active thymosin beta‑4 fragment mechanism[5][6]. Open source
Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if research goals require).
Dose Range: 500–1000 mcg daily with gradual titration (~5 mg/week average).
Reconstitution: 3.0 mL per 10 mg vial (~3.33 mg/mL) for accurate unit measurements.
Storage: Lyophilized frozen; reconstituted refrigerated; avoid freeze–thaw cycles of reconstituted solution.

Dosing Protocol

Suggested daily titration approach.

Start: 500 mcg daily; increase by ~100–150 mcg every 2 weeks as tolerated.
Target: 750–1000 mcg daily by Weeks 5–12.
Frequency: Once per day (subcutaneous).
Cycle Length: 8–12 weeks; optional extension to 16 weeks based on research protocol.
Timing: Any consistent time daily; rotate injection sites systematically.

Storage Instructions

Proper storage preserves peptide quality and activity.

Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure[7]. Open source
Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); do not freeze reconstituted solution as freezing can denature peptides.
Allow vials to reach room temperature before opening to reduce condensation uptake.
Use reconstituted vials within 28 days when stored with bacteriostatic water preservative[8]. Open source

Important Notes

Practical considerations for consistency and safety in research protocols.

Use new sterile insulin syringes for each injection; dispose in a sharps container.
Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation and lipohypertrophy[9]. Open source
Inject slowly; wait a few seconds before withdrawing the needle to prevent backflow.
Document daily dose, injection site, and any observations to maintain consistency.
Regulatory Note: TB‑500 is banned by WADA for athletic use and is not FDA‑approved for human administration[10]. Open source

How This Works

TB‑500 represents the N‑terminal active fragment of thymosin beta‑4, specifically the heptapeptide sequence Ac‑LKKTETQ[1][2]. This region is responsible for the actin‑binding and cell‑migration properties of the full thymosin molecule. Preclinical studies demonstrate that TB‑500 promotes angiogenesis, accelerates wound healing, and supports tissue regeneration by upregulating cell motility and blood vessel formation[5][6]. Research in animal models shows enhanced collagen deposition and reduced healing time in injury sites treated with thymosin fragments[11]. Recent metabolic studies suggest TB‑500 may act as a prodrug, cleaving to an active pentapeptide metabolite that drives biological activity[12].

Lifestyle Factors

Complementary strategies for optimal research outcomes.

Maintain adequate protein intake to support tissue repair and regeneration processes.
Combine with appropriate physical activity; avoid overtraining during injury recovery phases.
Prioritize sleep (7–9 hours) to maximize natural recovery and repair mechanisms.
Manage stress levels through evidence‑based practices to support overall healing.

Potential Benefits & Side Effects

Observations from preclinical and veterinary literature.

Supports accelerated wound healing and tissue repair through enhanced angiogenesis and cell migration[5][6]. Open source
May reduce inflammation and fibrosis indirectly via thymosin pathways observed in animal models[11]. Open source
Generally well tolerated in veterinary studies; occasional mild injection‑site reactions (redness, tenderness) reported.
Human safety data is limited; no large‑scale clinical trials have been completed for TB‑500 specifically[13]. Open source

Injection Technique

General subcutaneous guidance from clinical best‑practice resources[14][15].

Clean the vial stopper and skin with alcohol; allow to air dry completely.
Pinch a skinfold at the injection site; insert the needle at 45–90° into subcutaneous tissue[14]. Open source
Do not aspirate for subcutaneous injections; inject slowly and steadily[14]. Open source
Rotate sites systematically within approved areas (abdomen, thighs, upper arms) to avoid lipohypertrophy[9]. Open source
Wait 5–10 seconds after injection before withdrawing needle to prevent medication leakage.

Recommended Source

We recommend Prime Lab Peptides for high‑purity TB‑500 (10 mg).

High‑purity peptides (≥99%) with third‑party testing and batch‑specific COAs.
Consistent quality control and ISO‑aligned handling procedures.
Reliable fulfillment with proper cold‑chain shipping to maintain peptide integrity.
Transparent documentation for research compliance.

Important Note

This page is informational and does not authorize use. Peptify clients should complete assessment, disclose medications and health history, and follow the clinician-approved plan only.

Do not start, stop, combine, or change a protocol based only on website content.
Emergency symptoms require urgent medical care, not a website or routine follow-up message.

References